Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for DaVita Inc. (DVA:NYSE), powered by AI.
DaVita Inc. is currently trading at $208.98. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for DaVita Inc. on Alpha Lenz.
DaVita Inc.'s P/E ratio is 20.8.
“DaVita Inc. trades at a P/E of 20.8 (fair value) with modest ROE of -281.8%.”
Ask for details →DaVita Inc. is a prominent player in the healthcare sector, specializing in kidney care services. As a leading provider of dialysis services in the United States, DaVita operates numerous dialysis centers and provides care for patients with chronic kidney failure and end-stage renal disease. The primary function of the company is to deliver life-sustaining dialysis treatments to improve quality of life and extend survival for those affected by kidney-related health issues. DaVita's offerings include hemodialysis and peritoneal dialysis, catering to diverse patient needs. It also engages in ancillary services such as laboratory testing and management services for outpatient services. Recognized for its extensive network and focus on innovation in patient care, DaVita plays a crucial role in the healthcare industry by addressing the growing demand for specialized treatment. With a commitment to clinical excellence and operational efficiency, DaVita contributes significantly to the healthcare system by improving patient outcomes and providing accessible care solutions nationwide.
“DaVita Inc. trades at a P/E of 20.8 (fair value) with modest ROE of -281.8%.”
Ask for details →DaVita Inc. (ticker: DVA) is a company listed on NYSE in the Healthcare sector (Medical Care Facilities). It has approximately 76,000 employees. Market cap is $15.5B.
The current price is $208.98 with a P/E ratio of 20.77x and P/B of -23.82x.
ROE is -281.83% and operating margin is 14.74%. Annual revenue is $13.6B.